Reactive Oxygen Species Synergize to Potently and Selectively Induce Cancer Cell Death

ACS Chemical Biology

Volumn 12, Issue 5, 2017, Pages 1416-1424

  Lee, Hyang Yeon ^a   Parkinson, Elizabeth I ^a   Granchi, Carlotta ^b   Paterni, Ilaria ^b   Panigrahy, Dipak ^c   Seth, Pankaj ^c   Minutolo, Filippo ^b   Hergenrother, Paul J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DEFEROXAMINE; DEOXYNYBOQUINONE; DICOUMAROL; ELESCLOMOL; GLUCOSE; GLUCOSE TRANSPORTER 1; HYDROGEN PEROXIDE; MENADIONE; NHI GLC 2; OXIDOREDUCTASE INHIBITOR; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG; ISOENZYME; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL DEATH; CELL KILLING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FENTON REACTION; FLOW CYTOMETRY; GLUCOSE TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CANCER; LUNG METASTASIS; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG POTENTIATION; LUNG NEOPLASMS; NEOPLASMS; PATHOLOGY;

ANIMALS; CELL DEATH; DRUG SYNERGISM; HYDROGEN PEROXIDE; ISOENZYMES; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MICE; NEOPLASMS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 85019592597     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.7b00015     Document Type: Article

References (55)

1. Gorrini, C., Harris, I. S., and Mak, T. W. (2013) Modulation of oxidative stress as an anticancer strategy Nat. Rev. Drug Discovery 12, 931-947 10.1038/nrd4002
2. Griffith, O. (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis J. Biol. Chem. 257, 13704-13712
3. Kirshner, J. R., He, S., Balasubramanyam, V., Kepros, J., Yang, C.-Y., Zhang, M., Du, Z., Barsoum, J., and Bertin, J. (2008) Elesclomol induces cancer cell apoptosis through oxidative stress Mol. Cancer Ther. 7, 2319-2327 10.1158/1535-7163.MCT-08-0298
4. Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J., and Waxman, S. (2002) Mechanisms of action of arsenic trioxide Cancer Res. 62, 3893-3903
5. Sullivan, L. B. and Chandel, N. S. (2014) Mitochondrial reactive oxygen species and cancer Cancer Metab. 2, 17 10.1186/2049-3002-2-17
6. Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., and Huang, P. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate Cancer Cell 10, 241-252 10.1016/j.ccr.2006.08.009
7. Parkinson, E. I. and Hergenrother, P. J. (2011) Runaway ROS as a selective anticancer strategy ChemMedChem 6, 1957-1959 10.1002/cmdc.201100381
8. Trachootham, D., Alexandre, J., and Huang, P. (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery 8, 579-591 10.1038/nrd2803
9. Wondrak, G. T. (2009) Redox-directed cancer therapeutics: molecular mechanisms and opportunities Antioxid. Redox Signaling 11, 3013-3069 10.1089/ars.2009.2541
10. Halasi, M., Pandit, B., Wang, M., Nogueira, V., Hay, N., and Gartel, A. L. (2013) Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth Am. J. Pathol. 183, 257-265 10.1016/j.ajpath.2013.03.012
11. Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., and Kakizuka, A. (2004) Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine Cell Death Differ. 11, 737-746 10.1038/sj.cdd.4401389
12. Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., and Huang, P. (2003) Inhibition of mitochondrial respiration a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism J. Biol. Chem. 278, 37832-37839 10.1074/jbc.M301546200
13. Tomasetti, M., Santarelli, L., Alleva, R., Dong, L.-F., and Neuzil, J. (2015) Redox-active and redox-silent compounds: synergistic therapeutics in cancer Curr. Med. Chem. 22, 552-568 10.2174/0929867321666140915142219
14. Auten, R. L. and Davis, J. M. (2009) Oxygen toxicity and reactive oxygen species: the devil is in the details Pediatr. Res. 66, 121-127 10.1203/PDR.0b013e3181a9eafb
15. Giorgio, M., Trinei, M., Migliaccio, E., and Pelicci, P. G. (2007) Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat. Rev. Mol. Cell Biol. 8, 722-728 10.1038/nrm2240
16. Thannickal, V. J. and Fanburg, B. L. (2000) Reactive oxygen species in cell signaling Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1005-L1028
17. Indo, H. P., Yen, H.-C., Nakanishi, I., Matsumoto, K.-i., Tamura, M., Nagano, Y., Matsui, H., Gusev, O., Cornette, R., Okuda, T., Minamiyama, Y., St. Clair, D. K., and Majima, H. J. et al. 2015, A mitochondrial superoxide theory for oxidative stress diseases and aging J. Clin. Biochem. Nutr. 56, 1-7 10.3164/jcbn.14-42
18. Buettner, G. R. and Jurkiewicz, B. A. (1996) Catalytic metals, ascorbate and free radicals: combinations to avoid Radiat. Res. 145, 532-541 10.2307/3579271
19. Dixon, S. J. and Stockwell, B. R. (2014) The role of iron and reactive oxygen species in cell death Nat. Chem. Biol. 10, 9-17 10.1038/nchembio.1416
20. Tong, L., Chuang, C.-C., Wu, S., and Zuo, L. (2015) Reactive oxygen species in redox cancer therapy Cancer Lett. 367, 18-25 10.1016/j.canlet.2015.07.008
21. Bair, J. S., Palchaudhuri, R., and Hergenrother, P. J. (2010) Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death J. Am. Chem. Soc. 132, 5469-5478 10.1021/ja100610m
22. Huang, X., Dong, Y., Bey, E. A., Kilgore, J. A., Bair, J. S., Li, L.-S., Patel, M., Parkinson, E. I., Wang, Y., Williams, N. S., Gao, J., Hergenrother, P. J., and Boothman, D. A. (2012) An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis Cancer Res. 72, 3038-3047 10.1158/0008-5472.CAN-11-3135
23. Parkinson, E. I., Bair, J. S., Cismesia, M., and Hergenrother, P. J. (2013) Efficient NQO1 substrates are potent and selective anticancer agents ACS Chem. Biol. 8, 2173-2183 10.1021/cb4005832
24. Parkinson, E. I. and Hergenrother, P. J. (2015) Deoxynyboquinones as NQO1-Activated Cancer Therapeutics Acc. Chem. Res. 48, 2715-2723 10.1021/acs.accounts.5b00365
25. Calvaresi, E. C., Granchi, C., Tuccinardi, T., Di Bussolo, V., Huigens, R. W., III, Lee, H. Y., Palchaudhuri, R., Macchia, M., Martinelli, A., Minutolo, F., and Hergenrother, P. J. (2013) Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor ChemBioChem 14, 2263-2267 10.1002/cbic.201300562
26. Malkinson, A. M., Siegel, D., Forrest, G. L., Gazdar, A. F., Oie, H. K., Chan, D. C., Bunn, P. A., Mabry, M., Dykes, D. J., Harrison, J., Steadman, D., and Ross, D. (1992) Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C Cancer Res. 52, 4752-4757
27. Siegel, D. and Ross, D. (2000) Immunodetection of NAD (P) H: quinone oxidoreductase 1 (NQO1) in human tissues Free Radical Biol. Med. 29, 246-253 10.1016/S0891-5849(00)00310-5
28. Yang, Y., Zhang, Y., Wu, Q., Cui, X., Lin, Z., Liu, S., and Chen, L. (2014) Clinical implications of high NQO1 expression in breast cancers J. Exp. Clin. Cancer Res. 33, 14 10.1186/1756-9966-33-14
29. Li, Z., Zhang, Y., Jin, T., Men, J., Lin, Z., Qi, P., Piao, Y., and Yan, G. (2015) NQO1 protein expression predicts poor prognosis of non-small cell lung cancers BMC Cancer 15, 207 10.1186/s12885-015-1227-8
30. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324, 1029-1033 10.1126/science.1160809
31. Koukourakis, M., Giatromanolaki, A., Sivridis, E., Bougioukas, G., Didilis, V., Gatter, K., and Harris, A. (2003) Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis Br. J. Cancer 89, 877-885 10.1038/sj.bjc.6601205
32. Fantin, V. R., St-Pierre, J., and Leder, P. (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance Cancer Cell 9, 425-434 10.1016/j.ccr.2006.04.023
33. Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., and Dang, C. V. (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression Proc. Natl. Acad. Sci. U. S. A. 107, 2037-2042 10.1073/pnas.0914433107
34. Chou, T.-C. (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol. Rev. 58, 621-681 10.1124/pr.58.3.10
35. Vichai, V. and Kirtikara, K. (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening Nat. Protoc. 1, 1112-1116 10.1038/nprot.2006.179
36. Zhu, H., Bannenberg, G. L., Moldéus, P., and Shertzer, H. G. (1994) Oxidation pathways for the intracellular probe 2′, 7′-dichlorofluorescin Arch. Toxicol. 68, 582-587 10.1007/s002040050118
37. Criddle, D. N., Gillies, S., Baumgartner-Wilson, H. K., Jaffar, M., Chinje, E. C., Passmore, S., Chvanov, M., Barrow, S., Gerasimenko, O. V., Tepikin, A. V., Sutton, R., and Petersen, O. H. (2006) Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells J. Biol. Chem. 281, 40485-40492 10.1074/jbc.M607704200
38. Huang, P., Feng, L., Oldham, E. A., Keating, M. J., and Plunkett, W. (2000) Superoxide dismutase as a target for the selective killing of cancer cells Nature 407, 390-395 10.1038/35030140
39. Allensworth, J. L., Aird, K. M., Aldrich, A. J., Batinic-Haberle, I., and Devi, G. R. (2012) XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells Mol. Cancer Ther. 11, 1518-1527 10.1158/1535-7163.MCT-11-0787
40. Nakahara, T., Takeuchi, M., Kinoyama, I., Minematsu, T., Shirasuna, K., Matsuhisa, A., Kita, A., Tominaga, F., Yamanaka, K., Kudoh, M., and Sasamata, M. (2007) YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts Cancer Res. 67, 8014-8021 10.1158/0008-5472.CAN-07-1343
41. Winter, G. E., Radic, B., Mayor-Ruiz, C., Blomen, V. A., Trefzer, C., Kandasamy, R. K., Huber, K. V., Gridling, M., Chen, D., Klampfl, T., Kralovics, R., Kubicek, S., Fernandez-Capetillo, O., Brummelkamp, T. R., and Superti-Furga, G. (2014) The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity Nat. Chem. Biol. 10, 768-773 10.1038/nchembio.1590
42. Abe, K. and Saito, H. (1998) Characterization of t-Butyl Hydroperoxide Toxicity in Cultured Rat Cortical Neurones and Astrocytes Pharmacol. Toxicol. 83, 40-46 10.1111/j.1600-0773.1998.tb01440.x
43. Kang, S. W., Lee, S., and Lee, E. K. (2015) ROS and energy metabolism in cancer cells: alliance for fast growth Arch. Pharm. Res. 38, 338-345 10.1007/s12272-015-0550-6
44. Liemburg-Apers, D. C., Willems, P. H., Koopman, W. J., and Grefte, S. (2015) Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism Arch. Toxicol. 89, 1209-1226 10.1007/s00204-015-1520-y
45. Dang, C. V., Kim, J.-w., Gao, P., and Yustein, J. (2008) The interplay between MYC and HIF in cancer Nat. Rev. Cancer 8, 51-56 10.1038/nrc2274
46. Lundberg, A. P., Francis, J. M., Pajak, M., Parkinson, E. I., Wycislo, K. L., Rosol, T. J., Brown, M. E., London, C. A., Dirikolu, L., Hergenrother, P. J., and Fan, T. M. (2017) Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species Invest. New Drugs 35, 134-144 10.1007/s10637-016-0414-z
47. Glasauer, A. and Chandel, N. S. (2014) Targeting antioxidants for cancer therapy Biochem. Pharmacol. 92, 90-101 10.1016/j.bcp.2014.07.017
48. Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., and Aggarwal, B. B. (2012) Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy Antioxid. Redox Signaling 16, 1295-1322 10.1089/ars.2011.4414
49. Sborov, D. W., Haverkos, B. M., and Harris, P. J. (2015) Investigational cancer drugs targeting cell metabolism in clinical development Expert Opin. Invest. Drugs 24, 79-94 10.1517/13543784.2015.960077
50. Foufelle, F. and Fromenty, B. (2016) Role of endoplasmic reticulum stress in drug-induced toxicity Pharmacol. Res. Perspect. 4, e00211 10.1002/prp2.211
51. Pink, J. J., Planchon, S. M., Tagliarino, C., Varnes, M. E., Siegel, D., and Boothman, D. A. (2000) NAD (P) H: quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity J. Biol. Chem. 275, 5416-5424 10.1074/jbc.275.8.5416
52. Tudor, G., Gutierrez, P., Aguilera-Gutierrez, A., and Sausville, E. A. (2003) Cytotoxicity and apoptosis of benzoquinones: redox cycling, cytochrome c release, and BAD protein expression Biochem. Pharmacol. 65, 1061-1075 10.1016/S0006-2952(03)00013-3
53. Li, L. S., Bey, E. A., Dong, Y., Meng, J., Patra, B., Yan, J., Xie, X. J., Brekken, R. A., Barnett, C. C., Bornmann, W. G., Gao, J., and Boothman, D. A. (2011) Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy Clin. Cancer Res. 17, 275-285 10.1158/1078-0432.CCR-10-1983
54. Bey, E. A., Reinicke, K. E., Srougi, M. C., Varnes, M., Anderson, V. E., Pink, J. J., Li, L. S., Patel, M., Cao, L., Moore, Z., Rommel, A., Boatman, M., Lewis, C., Euhus, D. M., Bornmann, W. G., Buchsbaum, D. J., Spitz, D. R., Gao, J., and Boothman, D. A. (2013) Catalase Abrogates β-Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers Mol. Cancer Ther. 12, 2110-2120 10.1158/1535-7163.MCT-12-0962
55. Li, L.-S., Reddy, S., Lin, Z.-H., Liu, S., Park, H., Chun, S. G., Bornmann, W. G., Thibodeaux, J., Yan, J., Chakrabarti, G., Xie, X. J., Sumer, B. D., Boothman, D. A., and Yordy, J. S. (2016) NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer Mol. Cancer Ther. 15, 1757-1767 10.1158/1535-7163.MCT-15-0765